Children's Hospital Colorado
Tim Bernard, MD
Neuroscience

Tim Bernard, MD

Associate Professor of Pediatrics, Neurology and Child Neurology
Director, Colorado Pediatric Stroke Program

Specialties:
Neurology
Conditions:
Stroke, Clotting Disorders, Obesity
specialties:

Neurology

conditions:

Stroke, Clotting Disorders, Obesity

Meet Tim Bernard, MD

I want all of my patients and their families to know that their child is getting the best care possible. In order to support this goal, I strive to listen to the needs of the family and patient, and educate them about their child's disease.

Get to know his background

My many clinical interests include childhood stroke, childhood CSVT, and general neurology

Undergraduate 1994

Middlebury College (VT)

Medical School 2001

University of Rochester School of Medicine and Dentistry

Internship 2002

University of Colorado (Children's Hospital Colorado) Program

Residency 2006

University of Colorado (Children's Hospital Colorado) Program, Child Neurology

Graduate 2013

University of Colorado Health Sciences Center

Best Doctors in America 2015

Physicians are selected based on the result of an extensive, confidential peer-review process
Best Doctors in America

Golden Stethoscope Award 2016

Awardee, Golden Stethoscope Banquet, in recognition for excellence in clinical education.
University of Colorado

5280 Top Doc 2016

Selected as one of 87 top specialist in the Denver Metro Area by peer voting. 5280 Magazine
5280 Magazine

For Patients:
I study children with stroke, and try to understand the mechanisms behind why children have strokes. Specifically, I investigate the potential of hypercoagulable and inflammatory biomarkers in prognosticating outcome and recurrence in childhood-onset arterial ischemic stroke.
For Referring Providers:
We are trying to use special global assays to ascertain which patients are at higher risk for recurrent stroke after their initial event. In addition, I'm interested in studying classification of childhood stroke since childhood stroke is a rare disease. All efforts to determine risk factors, treatments and outcomes need to be multicenter, therefore having a well validated and reliable classification system is imperative in studying this disease.

Associate Professor of Pediatrics, Neurology and Child Neurology

Director, Colorado Pediatric Stroke Program


PRODWEBSERVER2